Dow Up 0.76% Nasdaq Up 0.69%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.17 Down 0.03(1.36%) Oct 24, 4:00PM EDT
Prev Close:2.20
Open:2.23
Bid:2.14 x 200
Ask:2.44 x 500
1y Target Est:8.04
Beta:1.15
Next Earnings Date:30-Oct-14OGXI Earnings announcement
Day's Range:2.15 - 2.26
52wk Range:2.10 - 14.25
Volume:59,931
Avg Vol (3m):139,727
Market Cap:45.87M
P/E (ttm):N/A
EPS (ttm):-2.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OGXI

Comparison

Symbol% ChgMkt Cap
OGXIDown 1.36%45.87M
BMYUp 2.15%88.91B
CELGUp 2.83%82.54B
PFEUp 1.78%184.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.68
Quarterly EPS Est (Sep-14) :-0.37
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback